Exosome / Therapeutic vector / Therapeutic antibody / Vaccine / GPCR / Kinase receptor / transporter / Oncology / Neuronal disease / Infectious disease / Heart disease / BBB

Ciloa is the most experienced exosome-based R&D powerhouse dedicated to the development of innovative preventive and therapeutic solutions. Its disruptive in vivo technology customizes exosomes with any membrane and/or cytosolic proteins allowing to:

• create virus-free exosome-based therapeutic vectors with the potential to deliver specifically chosen cargos to any diseased organ;
• therapeutic antibodies against challenging targets (GPCRs, kinase receptors, ion channels, transporters, viral envelope proteins…);
• virus-free & adjuvant-free vaccines against emerging viruses.